113 related articles for article (PubMed ID: 37777054)
21. Exposure to a low pathogenic A/H7N2 virus in chickens protects against highly pathogenic A/H7N1 virus but not against subsequent infection with A/H5N1.
Vergara-Alert J; Moreno A; Zabala JG; Bertran K; Costa TP; Cordón I; Rivas R; Majó N; Busquets N; Cordioli P; Rodriguez F; Darji A
PLoS One; 2013; 8(3):e58692. PubMed ID: 23469288
[TBL] [Abstract][Full Text] [Related]
22. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
[TBL] [Abstract][Full Text] [Related]
23. Clade 2.3.4.4b H5N1 high pathogenicity avian influenza virus (HPAIV) from the 2021/22 epizootic is highly duck adapted and poorly adapted to chickens.
James J; Billington E; Warren CJ; De Sliva D; Di Genova C; Airey M; Meyer SM; Lewis T; Peers-Dent J; Thomas SS; Lofts A; Furman N; Nunez A; Slomka MJ; Brown IH; Banyard AC
J Gen Virol; 2023 May; 104(5):. PubMed ID: 37167079
[TBL] [Abstract][Full Text] [Related]
24. Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens.
Kim SH; Paldurai A; Xiao S; Collins PL; Samal SK
Vaccine; 2014 Jul; 32(35):4428-4435. PubMed ID: 24968158
[TBL] [Abstract][Full Text] [Related]
25. A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge.
Shirvani E; Varghese BP; Paldurai A; Samal SK
Sci Rep; 2020 Feb; 10(1):2221. PubMed ID: 32042001
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of rHVT-AI vector vaccine in broilers with passive immunity against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.
Rauw F; Palya V; Gardin Y; Tatar-Kis T; Dorsey KM; Lambrecht B; van den Berg T
Avian Dis; 2012 Dec; 56(4 Suppl):913-22. PubMed ID: 23402112
[TBL] [Abstract][Full Text] [Related]
27. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
28. Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice.
Cornelissen LA; de Leeuw OS; Tacken MG; Klos HC; de Vries RP; de Boer-Luijtze EA; van Zoelen-Bos DJ; Rigter A; Rottier PJ; Moormann RJ; de Haan CA
PLoS One; 2012; 7(8):e44447. PubMed ID: 22952980
[TBL] [Abstract][Full Text] [Related]
29. A genetically engineered H5 protein expressed in insect cells confers protection against different clades of H5N1 highly pathogenic avian influenza viruses in chickens.
Oliveira Cavalcanti M; Vaughn E; Capua I; Cattoli G; Terregino C; Harder T; Grund C; Vega C; Robles F; Franco J; Darji A; Arafa AS; Mundt E
Avian Pathol; 2017 Apr; 46(2):224-233. PubMed ID: 27807985
[TBL] [Abstract][Full Text] [Related]
30. Prior infection of chickens with H1N1 or H1N2 avian influenza elicits partial heterologous protection against highly pathogenic H5N1.
Nfon C; Berhane Y; Pasick J; Embury-Hyatt C; Kobinger G; Kobasa D; Babiuk S
PLoS One; 2012; 7(12):e51933. PubMed ID: 23240067
[TBL] [Abstract][Full Text] [Related]
31. Heterologous post-infection immunity against Egyptian avian influenza virus (AIV) H9N2 modulates the course of subsequent infection by highly pathogenic AIV H5N1, but vaccination immunity does not.
Naguib MM; Grund C; Arafa AS; Abdelwhab EM; Beer M; Harder TC
J Gen Virol; 2017 Jun; 98(6):1169-1173. PubMed ID: 28590242
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge.
Bublot M; Pritchard N; Cruz JS; Mickle TR; Selleck P; Swayne DE
Avian Dis; 2007 Mar; 51(1 Suppl):498-500. PubMed ID: 17494618
[TBL] [Abstract][Full Text] [Related]
33. The new temperature-sensitive mutation PA-F35S for developing recombinant avian live attenuated H5N1 influenza vaccine.
Zhang W; Tu J; Zhao Z; Chen H; Jin M
Virol J; 2012 May; 9():97. PubMed ID: 22621130
[TBL] [Abstract][Full Text] [Related]
34. Highly Pathogenic Avian Influenza Virus (H5N1) Clade 2.3.4.4b Introduced by Wild Birds, China, 2021.
Tian J; Bai X; Li M; Zeng X; Xu J; Li P; Wang M; Song X; Zhao Z; Tian G; Liu L; Guan Y; Li Y; Chen H
Emerg Infect Dis; 2023 Jul; 29(7):1367-1375. PubMed ID: 37347504
[TBL] [Abstract][Full Text] [Related]
35. Highly pathogenic avian influenza virus infection in chickens but not ducks is associated with elevated host immune and pro-inflammatory responses.
Kuchipudi SV; Tellabati M; Sebastian S; Londt BZ; Jansen C; Vervelde L; Brookes SM; Brown IH; Dunham SP; Chang KC
Vet Res; 2014 Nov; 45(1):118. PubMed ID: 25431115
[TBL] [Abstract][Full Text] [Related]
36. Influenza A pathway analysis of highly pathogenic avian influenza virus (H5N1) infection in genetically disparate Ri chicken lines.
Lee J; Hong Y; Vu TH; Lee S; Heo J; Truong AD; Lillehoj HS; Hong YH
Vet Immunol Immunopathol; 2022 Apr; 246():110404. PubMed ID: 35231674
[TBL] [Abstract][Full Text] [Related]
37. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate.
Grund C; Abdelwhab el-SM; Arafa AS; Ziller M; Hassan MK; Aly MM; Hafez HM; Harder TC; Beer M
Vaccine; 2011 Jul; 29(33):5567-73. PubMed ID: 21244859
[TBL] [Abstract][Full Text] [Related]
38. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
Connie Leung YH; Luk G; Sia SF; Wu YO; Ho CK; Chow KC; Tang SC; Guan Y; Malik Peiris JS
Vaccine; 2013 Aug; 31(35):3536-42. PubMed ID: 23791547
[TBL] [Abstract][Full Text] [Related]
39. Experimental and Field Results Regarding Immunity Induced by a Recombinant Turkey Herpesvirus H5 Vector Vaccine Against H5N1 and Other H5 Highly Pathogenic Avian Influenza Virus Challenges.
Gardin Y; Palya V; Dorsey KM; El-Attrache J; Bonfante F; Wit Sd; Kapczynski D; Kilany WH; Rauw F; Steensels M; Soejoedono RD
Avian Dis; 2016 May; 60(1 Suppl):232-7. PubMed ID: 27309060
[TBL] [Abstract][Full Text] [Related]
40. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
